The Ethical Allocation of Remdesivir Within Hospitals

Date
2021
Language
American English
Embargo Lift Date
Committee Members
Degree
Degree Year
Department
Grantor
Journal Title
Journal ISSN
Volume Title
Found At
Abstract

Recent evidence has shown that remdesivir may shorten length of hospital stay and recovery in COVID-19 patients. Many hospitals are experiencing shortages of remdesivir and are being forced to determine systems for the ethical allocation of this drug. Ethical allocation of remdesivir is imperative for upholding principles of justice during public health crisis.2 Currently, there is no consensus on the ethical distribution of remdesivir to patients within hospitals. This article discusses places of consensus, variance, and limitations of hospital level remdesivir allocation policies throughout the US during the COVID-19 pandemic.

Description
item.page.description.tableofcontents
item.page.relation.haspart
Cite As
Comer, A. R. (2021). The Ethical Allocation of Remdesivir Within Hospitals. The Journal of Hospital Ethics, 7(2), 82–84.
ISSN
Publisher
Series/Report
Sponsorship
Major
Extent
Identifier
Relation
Journal
The Journal of Hospital Ethics
Rights
Publisher Policy
Source
Author
Alternative Title
Type
Article
Number
Volume
Conference Dates
Conference Host
Conference Location
Conference Name
Conference Panel
Conference Secretariat Location
Version
Author's manuscript
Full Text Available at
This item is under embargo {{howLong}}